Design and Analysis Considerations for a Sequentially Randomized HIV Prevention Trial

被引：0
|
作者：
David Benkeser
Keith Horvath
Cathy J. Reback
Joshua Rusow
Michael Hudgens
机构：
[1] Friends Research Institute,
[2] Inc,undefined
来源：
Statistics in Biosciences | 2020年 / 12卷
关键词：
Randomized trial; SMART; HIV prevention; Targeted learning; MHealth;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The TechStep study is an ongoing randomized controlled trial in HIV-negative transgender youths and young adults, which will evaluate the efficacy of mobile health interventions for reducing risk behaviors. Several mobile interventions are available, which complicates the design. To evaluate different combinations of mHealth interventions, TechStep is utilizing a sequentially randomized design. In this work, we discuss the motivation for this design, propose robust methodology for the analysis of the trial, and evaluate the methodology via simulation.
引用
收藏
页码：446 / 467
页数：21
相关论文
共 50 条
  • [1] Design and Analysis Considerations for a Sequentially Randomized HIV Prevention Trial
    Benkeser, David
    Horvath, Keith
    Reback, Cathy J.
    Rusow, Joshua
    Hudgens, Michael
    STATISTICS IN BIOSCIENCES, 2020, 12 (03) : 446 - 467
  • [2] HIV Treatment as Prevention: Considerations in the Design, Conduct, and Analysis of Cluster Randomized Controlled Trials of Combination HIV Prevention
    Boily, Marie-Claude
    Masse, Benoit
    Alsallaq, Ramzi
    Padian, Nancy S.
    Eaton, Jeffrey W.
    Vesga, Juan F.
    Hallett, Timothy B.
    PLOS MEDICINE, 2012, 9 (07)
  • [3] Sample size considerations in the design of cluster randomized trials of combination HIV prevention
    Wang, Rui
    Goyal, Ravi
    Lei, Quanhong
    Essex, M.
    De Gruttola, Victor
    CLINICAL TRIALS, 2014, 11 (03) : 309 - 318
  • [4] Bioethical and Biostatistical Considerations of Innovative HIV Prevention Trial Designs
    Sachdev, Darpun D.
    Whitacre, Ryan
    Buchbinder, Susan P.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A91 - A91
  • [5] Prevention Trial in the Cherokee Nation: Design of a Randomized Community Trial
    Komro, Kelli A.
    Wagenaar, Alexander C.
    Boyd, Misty
    Boyd, B. J.
    Kominsky, Terrence
    Pettigrew, Dallas
    Tobler, Amy L.
    Lynne-Landsman, Sarah D.
    Livingston, Melvin D.
    Livingston, Bethany
    Molina, Mildred M. Maldonado
    PREVENTION SCIENCE, 2015, 16 (02) : 291 - 300
  • [6] Pharmacogenetics in randomized controlled trials: considerations for trial design
    van der Baan, Frederieke H.
    Klungel, Olaf H.
    Egberts, Antoine C. G.
    Leufkens, Hubert G.
    Grobbee, Diederick E.
    Roes, Kit C. B.
    Knol, Mirjam J.
    PHARMACOGENOMICS, 2011, 12 (10) : 1485 - 1492
  • [7] Prevention Trial in the Cherokee Nation: Design of a Randomized Community Trial
    Kelli A. Komro
    Alexander C. Wagenaar
    Misty Boyd
    B. J. Boyd
    Terrence Kominsky
    Dallas Pettigrew
    Amy L. Tobler
    Sarah D. Lynne-Landsman
    Melvin D. Livingston
    Bethany Livingston
    Mildred M. Maldonado Molina
    Prevention Science, 2015, 16 : 291 - 300
  • [8] Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention
    Dawson, Liza
    Zwerski, Sheryl
    BIOETHICS, 2015, 29 (05) : 316 - 323
  • [9] Establishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odyssey
    Cohen, Myron S.
    McCauley, Marybeth
    Sugarman, Jeremy
    CLINICAL TRIALS, 2012, 9 (03) : 340 - 347
  • [10] Considerations for Optimal Trial Design for Rheumatoid Arthritis Prevention Studies
    Cope, Andrew P.
    CLINICAL THERAPEUTICS, 2019, 41 (07) : 1299 - 1311
12345